Public Assessment Report for paediatric studies submitted in accordance with Article 46 of Regulation (EC) No1901 2006, as amended Daivobet - Betamethasone calcipotriol - Document - PDFSEARCH.IO

First Page	Meta Content
	Public Assessment Report for paediatric studies submitted in accordance with Article 46 of Regulation (EC) No1901/2006, as amended Daivobet Add to Reading List Document Date: 2014-06-03 11:07:05 Open Document File Size: 140,95 KB Share Result on Facebook Company AEs / Leo Pharma A/S / D05AX52 Pharmaceutical / / Country United States / / Event Product Recall / Product Issues / FDA Phase / / Facility Xamiol INN / / IndustryTerm medicinal product / pharmaceutical formulation / investigational product / medicinal products / study protocol / / MedicalCondition controlled disease / Scalp Psoriasis A / severe psoriasis / disease / scalp psoriasis / psoriasis / plaque psoriasis / / Position investigator / EXECUTIVE / / Product ACTH / betamethasone dipropionate / Taclonex / adverse drug reaction / Topical Suspension / Betamethasone / Daivobet / topical / Daivobet/Xamiol gel / Taclonex® Topical Suspension / / Technology study protocol / / SocialTag Medicine Pharmacology Secosteroids Vitamin D Psoriasis Calcipotriol Betamethasone/calcipotriol Betamethasone Cortisol Otologicals

Public Assessment Report for paediatric studies submitted in accordance with Article 46 of Regulation (EC) No1901/2006, as amended DaivobetAdd to Reading List